INMB earnings: a positive outcome, +26.3%

On March 11, 2020, INmune Bio, Inc. reached its earnings. The result was a positive outcome, and the stock moved +26.3% in the window around the event. It had already run -22.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.